Zobrazeno 1 - 10
of 201
pro vyhledávání: '"Elinor Ben Menachem"'
Autor:
Andres M. Kanner, Rohit Shankar, Nils G. Margraf, Bettina Schmitz, Elinor Ben-Menachem, Josemir W. Sander
Publikováno v:
Annals of General Psychiatry, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Epilepsy is one of the most common neurologic conditions. Its clinical manifestations are not restricted to seizures but often include cognitive disturbances and psychiatric disorders. Prospective population-based studies have shown that peo
Externí odkaz:
https://doaj.org/article/cb5471d9555543248c03aa27a2daed5f
Autor:
Bernhard J. Steinhoff, Elinor Ben-Menachem, Pavel Klein, Jukka Peltola, Bettina Schmitz, Rhys H. Thomas, Vicente Villanueva
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
The goal of epilepsy treatment is seizure freedom, typically with antiseizure medication (ASM). If patients fail to attain seizure control despite two trials of appropriately chosen ASMs at adequate doses, they are classified as having drug-resistant
Externí odkaz:
https://doaj.org/article/c6fb39da6f454b4eb48b2a31269c559b
Autor:
Bettina Schmitz, Simona Lattanzi, Kristl Vonck, Reetta Kälviäinen, Lina Nashef, Elinor Ben‐Menachem
Publikováno v:
Epilepsia Open, Vol 8, Iss 4, Pp 1241-1255 (2023)
Abstract Management of drug resistant epilepsy (DRE) represents a challenge to the treating clinician. This manuscript addresses DRE and provides an overview of treatment options, medical, surgical, and dietary. It addresses treatment strategies in p
Externí odkaz:
https://doaj.org/article/8edf72a9d52840b5947ca04b6a3c2dd9
Autor:
Elinor Ben‐Menachem, Jacqueline Dominguez, József Szász, Cynthia Beller, Charles Howerton, Lori Jensen, Carrie McClung, Robert Roebling, Björn Steiniger‐Brach
Publikováno v:
Epilepsia Open, Vol 6, Iss 3, Pp 618-623 (2021)
Abstract The primary objective of this trial (SP1042; NCT02582866) was to assess long‐term safety and tolerability of lacosamide monotherapy (200‐600 mg/day) in adults with focal (partial‐onset) seizures or generalized tonic‐clonic seizures (
Externí odkaz:
https://doaj.org/article/e81a1630b10d4915a70ef5863dd53e20
Autor:
Antonio Gil-Nagel, David Vossler, Elinor Ben-Menachem, W. LaFrance, Cynthia Harden, Jenny Qian, Gregory Beatch, Christopher Kenney
Publikováno v:
Wednesday, April 26.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbea314386ba1daa9f2c2ee831954f09
https://doi.org/10.1212/wnl.0000000000203311
https://doi.org/10.1212/wnl.0000000000203311
Autor:
Bernhard J. Steinhoff, Elinor Ben‐Menachem, Christian Brandt, Irene García Morales, William E. Rosenfeld, Estevo Santamarina, José M. Serratosa
Publikováno v:
Scientia
Cenobamate; Drug-resistant epilepsy; Seizures Cenobamato; Epilepsia resistente a los medicamentos; Convulsiones Cenobamat; Epilèpsia resistent a medicaments; Convulsions Objectives Cenobamate is an antiseizure medication (ASM) approved in Europe as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8b5ce9778ed19d59302309a47e50948
https://hdl.handle.net/11351/8121
https://hdl.handle.net/11351/8121
Autor:
Trevor Resnick, Joanne Rogin, Silvia Kochen, Yan Li, David Blum, Elinor Ben-Menachem, Patrício Soares-da-Silva, Laura Strom, Helena Gama, Todd Grinnell
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Objectives: To evaluate cutaneous allergic reactions in clinical trials of adjunctive eslicarbazepine acetate (ESL) for focal seizures. Materials and methods: Data were analyzed from three phase III randomized, double-blind, placebo-controlled studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82744f7d6bcd74d2c893056458e15251
https://doi.org/10.1111/ane.13218
https://doi.org/10.1111/ane.13218
Autor:
Gilmour Morrison, Carmen María Arenas Cabrera, Boudewijn Gunning, David Critchley, Julie Crockett, Manuel Toledo, Louise Wray, Kevan VanLandingham, Bola Tayo, Elinor Ben-Menachem
Publikováno v:
CNS Drugs
Background In recent randomized, placebo-controlled, phase III trials, highly purified cannabidiol demonstrated efficacy with an acceptable safety profile in patients with Lennox–Gastaut syndrome or Dravet syndrome. It is anticipated that antiepile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b32cab96f30b48559f58e5b435191b8c
http://europepmc.org/articles/PMC7275018
http://europepmc.org/articles/PMC7275018
Autor:
Björn Steiniger-Brach, Teresa Gasalla, Victor Biton, Hans Peter Grebe, Elinor Ben-Menachem, Marc De Backer, Melissa Brock, Kiyohito Terada, Ting Li, Lori Jensen
Publikováno v:
Epilepsia
Objective A large‐scale, double‐blind trial (SP0993; NCT01243177) demonstrated that lacosamide was noninferior to controlled‐release carbamazepine (carbamazepine‐CR) in terms of efficacy, and well tolerated as first‐line monotherapy in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bac1db1f8633cdeec7f03265d44cabb
http://europepmc.org/articles/PMC6988520
http://europepmc.org/articles/PMC6988520
Autor:
Kevin E. Chapman, Aradia Fu, Lawrence J. Hirsch, Lara Jehi, Alica M. Goldman, Barbara C. Jobst, Catherine A. Schevon, Shlomo Shinnar, Janelle L. Wagner, Elinor Ben-Menachem, Fred A. Lado, Michael R. Sperling, Timothy A. Simeone, Madona Plueger, Jong M. Rho, Eric H. Kossoff
Publikováno v:
Epilepsy Currents
The American Epilepsy Society Meeting in New Orleans attracted more than 5900 attendees. There was a lively exchange of new science, innovation, education, clinical practice, and many other items related to epilepsy. Educational symposia were a major
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eb2dbf10784e481463f12bc1c8e4e24
https://doi.org/10.1177/1535759719844486
https://doi.org/10.1177/1535759719844486